Allen Institute for Artificial Intelligence logo

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 2 years ago

Possible Interaction: Amphetamine and Central Nervous System Stimulants

Research Papers that Mention the Interaction

Converging evidence indicates that repeated exposure to motor stimulants such as cocaine and amphetamine produces marked alterations in network responsiveness of striatal neurons to subsequent challenge with the same stimulant drug.
Neurobiology of Learning and Memory  •  2005  |  View Paper
In recent years, use of cocaine and amphetamines and deaths associated with stimulants have been on the rise, and there are still no FDA-approved medications for stimulant use disorders.
Handbook of experimental pharmacology  •  2020  |  View Paper
These results demonstrate that intranasal administration of d‐amphetamine results in a more rapid onset compared to oral dosing, which could be associated with the popularity of intranasal prescription stimulant use and an enhanced potential for abuse.
Journal of clinical pharmacology  •  2011  |  View Paper
Drugs such as cocaine and amphetamines potentiate the effect of epinephrine and norepinephrine on the brain and act as stimulants.
Sleep medicine  •  2006  |  View Paper
Abuse of amphetamine and especially the stimulant look-alikes represent a serious problem in the United States.
The Psychiatric clinics of North America  •  1984  |  View Paper
It is not a central excitant, but rather is an antagonist of central stimulation produced by other agents in the mouse, including amphetamine , morphine, cocaine, and Meratran.
Neurology  •  1955  |  View Paper
The results suggest that amphetamine co-use may mask physical signs of alcohol dependency and add to the importance of educational strategies pointing out the potential problems associated with co-use of stimulants and alcohol.
Behavioural pharmacology  •  2018  |  View Paper
The development of the dopamine input to the medial prefrontal cortex occurs during adolescence and is a process that is vulnerable to disruption by stimulant drugs such as amphetamine.
Neuropsychopharmacology  •  2018  |  View Paper
These findings indicate that administration of the stimulant during the waking cycle compared to sleep cycle may significantly increase the potency of amphetamines to produce hyperthermia, neurotoxicity and lethality.
Neurotoxicology and teratology  •  2012  |  View Paper
Collectively, these data suggest that repeated AMPH exposure can lead to persistent disruption of dopaminergic modulation of BLA–mPFC circuitry, which may underlie impairments in cognitive/emotional processing observed in stimulant abusers.
The Journal of Neuroscience  •  2011  |  View Paper
Show More